Vudalimab (Anti-CTLA4 & PD-1)
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
2329669-72-7
XmAb 20717
PD-1/PD-L1
Apoptosis
Vudalimab is a bispecific antibody targeting PD-1 and CTLA-4 to inhibit immune checkpoint regulation and enhance immune responses. It is being developed for the treatment of advanced malignancies by promoting T-cell activation against tumors and metastatic castration-resistant prostate cancer (mCRPC) . M.W 125.43 kDa
-80°C (avoid freeze-thaw cycles)
Beschrijving
Vudalimab (Anti-CTLA4 & PD-1) Beschikbaar in 1 mg. Wordt geleverd met droogijs. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten
Anti-TAT (Thrombin-antithrombin) Antibody
ABS 014-22-1
1000 µL
Anti-APOE2 mouse monoclonal antibody
TD-AB0132
100 µg
CD35 (CR1) mouse monoclonal antibody, clone J3D3, Azide Free
BM2364
0.2 mg
Anti-KIR2DL1 (Rabbit, Monoclonal, Rabbit mAb)
A115392
100 µL
Stains-all
03943-5
5 g
Sudan Blue II;Oil Blue 35
TRC-S688913-500MG
500 mg
Nile Blue A
N8430-01
1 g
Human Apolipoprotein E2 (Apo E2) Antibody
22210-05011
150 µg
Recent gezochte producten
Anti-TAT (Thrombin-antithrombin)
ABS 014-22-1
1 mL
Anti-TAT (Thrombin-antithrombin)
ABS 014-22-04
400 µL
Thrombin-antithrombin monoclonal antibody (22)
BPD-ABS-014-22-1
1 mg
Thrombin-antithrombin monoclonal antibody (22)
BPD-ABS-014-22-04
400 µg
Uteroglobin recombinant monoclonal antibody (122)
ENZ-ABS1014-0100
100 µL
Anti-TAT (Thrombin-antithrombin) Antibody
ABS 014-22-010
100 µL
Anti-TAT (Thrombin-antithrombin) Antibody
ABS 014-22-04
400 uL
Anti-TAT (Thrombin-antithrombin) Antibody
ABS 014-22-1
1000 µL